Company Overview
Snapshot
Founded in February 2017 by Harel Manor and Lauren Gorelick, Fibioseq Medical operates with 1–10 employees. The company has raised $1.73M across four funding rounds. In January 2019, Fibioseq Medical secured Seed funding, advancing its development-stage solutions for wrist joint replacement.
Business overview
Fibioseq Medical is a development-stage company focused on improving patient care in total wrist implants within the Health Tech & Life Sciences sector. The company's core product, WristArt, is a patented Total Wrist Arthroplasty implant designed to preserve the natural biomechanics of the joint, offering near-normal range of motion for patients and simplifying procedures for surgeons. This medical device, featuring a double center of rotation, also aims to preserve critical blood flow to areas surrounding the prosthesis, serving the global medical devices industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Fibioseq Medical's primary product?
- Fibioseq Medical's primary product is WristArt, a patented Total Wrist Arthroplasty implant designed to improve wrist joint replacement solutions by preserving natural biomechanics and providing near-normal range of motion.
- When was Fibioseq Medical founded?
- Fibioseq Medical was founded in February 2017.
- Who are the founders of Fibioseq Medical?
- Fibioseq Medical was co-founded by Harel Manor and Lauren Gorelick.
- What is the current stage of Fibioseq Medical's product development?
- Fibioseq Medical's WristArt product is currently in the Clinical Trial stage, focusing on improving patient care in total wrist implants.
- Has Fibioseq Medical received any grants?
- Yes, Fibioseq Medical received a grant from the Israel Innovation Authority in April 2018 and another in January 2020.